Oncocyte Corporation Announces Proposed Public Offering of

IRVINE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), (“Oncocyte” or the “Company”), announced today that it has...

Related Keywords

New York ,United States ,Bob Yedid ,Megan Kernan ,Lifesci Advisors ,Company Determa ,Company Annual Report On Form ,Needham Company ,Exchange Commission ,Syndicate Prospectus Department ,Oncocyte Corporation ,Insight Genetics Inc ,Chronix Biomedical Inc ,Life Technologies Corporation ,Oncocyte Corporation Nasdaq ,Collaboration Agreement ,Thermo Fisher Scientific ,Oncomine Comprehensive Assay Plus ,Integrated Sequencer ,Purification System ,Chronix Biomedical ,Insight Genetics ,Private Securities Litigation Reform Act ,Risk Factors ,Annual Report ,Sci Advisors ,Nasdaq Ocx ,